Envitest Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.10 M
as on 14-12-2024
- Paid Up Capital ₹ 3.10 M
as on 14-12-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.15 Cr
as on 14-12-2024
- Revenue 90.25%
(FY 2022)
- Profit 144.21%
(FY 2022)
- Ebitda 69.27%
(FY 2022)
- Net Worth 57.23%
(FY 2022)
- Total Assets 17.96%
(FY 2022)
About Envitest Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.10 M and a paid-up capital of Rs 3.10 M.
The company currently has active open charges totaling ₹3.15 Cr.
Prabakaran Rajulu, Belagur Jashan, and Rohith Chandra serve as directors at the Company.
- CIN/LLPIN
U74999KA2017PTC105431
- Company No.
105431
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Aug 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Envitest Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabakaran Rajulu  | Director | 09-Aug-2017 | Current |
| Belagur Jashan | Director | 09-Aug-2017 | Current |
| Rohith Chandra | Director | 16-Aug-2023 | Current |
Financial Performance of Envitest Laboratories.
Envitest Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 90.25% increase. The company also saw a substantial improvement in profitability, with a 144.21% increase in profit. The company's net worth Soared by an impressive increase of 57.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Envitest Laboratories?
In 2022, Envitest Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Reefilo Technologies Private LimitedActive 1 year 16 daysBelagur Jashan and Rohith Chandra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 23 Oct 2024 | ₹2.01 M | Open |
Indian Overseas Bank Creation Date: 27 Jun 2022 | ₹1.49 Cr | Open |
Indian Overseas Bank Creation Date: 18 May 2022 | ₹1.00 M | Open |
How Many Employees Work at Envitest Laboratories?
Envitest Laboratories has a workforce of 22 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Envitest Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Envitest Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
